1 |
Chaudhry F, Munir R, Ashraf M, Mehr-un-nisa, Huma R, Malik N, Hussain S, Ali Munawar M, Ain Khan M. Exploring Facile Synthesis and Cholinesterase Inhibiting Potential of Heteroaryl Substituted Imidazole Derivatives for the Treatment of Alzheimer’s Disease. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.104384] [Reference Citation Analysis]
|
2 |
Khalid Z, Shafqat SS, Ahmad HA, Rehman HM, Munawar MA, Ahmad M, Asiri AM, Ashraf M. Synthesis of 1,2,3-benzotriazin-4(3H)-one derivatives as α-glucosidase inhibitor and their in-silico study. Med Chem Res. [DOI: 10.1007/s00044-022-02883-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Sardar A, Abid O, Daud S, Fakhar-e-alam M, Siddique MH, Ashraf M, Shahid W, Ejaz SA, Atif M, Ahmad S, Shafeeq S, Afzal M. Design, synthesis, in vitro and in silico studies of naproxen derivatives as dual lipoxygenase and α-glucosidase inhibitors. Journal of Saudi Chemical Society 2022. [DOI: 10.1016/j.jscs.2022.101468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Karami M, Hasaninejad A, Mahdavi H, Iraji A, Mojtabavi S, Faramarzi MA, Mahdavi M. One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors. Mol Divers 2021. [PMID: 34697701 DOI: 10.1007/s11030-021-10337-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Nasli Esfahani A, Iraji A, Alamir A, Moradi S, Asgari MS, Hosseini S, Mojtabavi S, Nasli-Esfahani E, Faramarzi MA, Bandarian F, Larijani B, Hamedifar H, Hajimiri MH, Mahdavi M. Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors. Mol Divers 2021. [PMID: 34515954 DOI: 10.1007/s11030-021-10310-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|